Oncolytic virus therapy is not a new discovery, but it may now be positioned as the next major breakthrough in cancer treatment following the success of checkpoint inhibitors in immunotherapy.

While the beauty industry works tirelessly to develop products that help with barrier repair and skin nourishment, few innovations have topped the popularity and efficacy of peptide lip products.

This article focuses on one of those potential combination therapies: oncolytic viruses (OVs). In the tug-of-war between fire (immune stimulation) and ice (immune suppression), ice usually wins ...